Vaccination for Inflammatory Bowel Disease Patients

Authors

  • Evy Yunihastuti Division of Allergy and Clinical Immunology, Department of Internal Medicine Faculty of Medicine, Universitas Indonesia /Dr. Cipto Mangunkusumo Hospital, Jakarta

DOI:

https://doi.org/10.24871/231202252-61

Keywords:

vaccine, inflammatory bowel disease, vaccination, Crohn’s disease, ulcerative collitis

Abstract

Inflammatory bowel disease (IBD) patients have an increased rate of some vaccine-preventable infection during their course of disease. However, the coverage of vaccination is still low. Many physicians often do not feel comfortable or confidence offering vaccination to IBD patients. Vaccine effectiveness can be altered by the immune dysregulation condition and immunosuppressive therapy that IBD patients use. There are also some concerns about IBD flare after vaccination and potential adverse events related to live vaccines. Nonetheless, offering vaccines and obtaining vaccination history is necessary for health care maintenance of IBD patients, especially those using immunosuppressive therapy.

Downloads

Published

2022-05-15

How to Cite

Yunihastuti, E. (2022). Vaccination for Inflammatory Bowel Disease Patients. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy, 23(1), 52–61. https://doi.org/10.24871/231202252-61